Evolent Health, Inc.
EVH · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20,864 | -$51,090 | -$64,618 | -$22,802 |
| Dep. & Amort. | $23,615 | $23,141 | $26,449 | $30,490 |
| Deferred Tax | $627 | -$865 | $295 | -$1,073 |
| Stock-Based Comp. | $0 | $0 | $11,081 | $0 |
| Change in WC | -$11,387 | -$59,415 | -$23,045 | -$45,278 |
| Other Non-Cash | $23,821 | $57,895 | $54,403 | $12,432 |
| Operating Cash Flow | $15,812 | -$30,334 | $4,565 | -$26,231 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$8,962 | -$8,770 | -$8,595 | -$6,151 |
| Net Acquisitions | $2 | -$51,549 | $0 | -$13,778 |
| Inv. Purchases | $0 | -$1,000 | $0 | -$1 |
| Inv. Sales/Matur. | $198 | $788 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$4,498 | $0 |
| Investing Cash Flow | -$8,762 | -$60,531 | -$13,093 | -$19,930 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,985 | $0 | $158,500 | $59,105 |
| Stock Issued | $0 | $0 | $0 | -$1 |
| Stock Repurch. | -$39,996 | -$28 | -$4,593 | $0 |
| Dividends Paid | $0 | -$4,621 | -$4,577 | $0 |
| Other Fin. Act. | -$1,875 | -$4,278 | -$41,476 | $42,644 |
| Financing Cash Flow | -$41,815 | -$8,927 | $107,854 | $96,942 |
| Forex Effect | -$259 | $12,369 | $23 | -$209 |
| Net Chg. in Cash | -$35,024 | -$87,423 | $99,349 | $50,572 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $175,363 | $262,786 | $178,496 | $112,926 |
| End Cash | $140,339 | $175,363 | $277,845 | $163,498 |
| Free Cash Flow | $6,850 | -$39,104 | -$4,030 | -$32,382 |